封面
市場調查報告書
商品編碼
2078232

靜脈輸液市場:按輸液類型、輸液袋類型、應用、最終用戶和地區分類的規模、佔有率、前景和機會分析(2025-2032 年)

Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,靜脈輸液市場規模將達到117.7億美元,2033年將達到182.9億美元。預計從2026年到2033年,該市場將以6.5%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 117.7億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.50% 2033年市場規模預測: 182.9億美元

靜脈輸液(IVF)是將液體直接注射到患者的靜脈循環系統。這些是無菌、無熱原的溶液,密封在單劑量容器中,用於靜脈注射,旨在補充體液和熱量。市面上有多種類型的靜脈輸液,包括氯化鈉溶液、乳酸林格氏液和可溶性葡萄糖溶液。靜脈輸液療法是治療營養不良和脫水患者的理想方法。脫水會導致多種問題,包括:

  • 體內重要礦物質(電解質)的平衡。
  • 認知(心理)功能。
  • 能階。
  • 胃腸功能(消化食物和產生尿液和糞便的能力)。
  • 頭痛的頻率和嚴重程度。
  • 身體素質。
  • 皮膚健康。

市場動態

預計腹瀉發病率的上升將推動全球靜脈輸液市場在預測期內成長。例如,聯合國兒童基金會(UNICEF)是聯合國負責向世界各地兒童提供人道主義和發展援助的機構,該機構於2022年7月發布報告稱,2020年全球五歲以下兒童死亡病例中,9%是由腹瀉造成的。報告也指出,每天有超過1,300名嬰兒死於腹瀉,每年全球整體約有48.4萬名兒童死於腹瀉。

此外,根據2018年9月發表在《採血針傳染病》雜誌上的報導,腹瀉是2016年失能調整後存活年(DALYs)損失的第三大原因,在全球整體造成7440萬DALYs損失。同一來源也通報稱,腹瀉是2016年全球第八大死因,造成1655944人死亡。

本研究的主要特點:

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場中具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球靜脈輸液市場主要參與者的概況:公司概況、財務表現、產品系列、企業發展區域、分銷策略、重大發展和策略。
  • 本報告提供的見解將使企業負責人和經營團隊能夠就未來的產品發布、政府措施、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份《全球靜脈輸液市場》報告旨在為行業內的各類相關人員提供參考,包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。
  • 相關人員可以透過利用各種用於分析全球靜脈輸液市場的策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 流行病學
  • 波特五力分析

第4章 全球靜脈輸液治療解決方案市場:依解決方案分類,2021-2033年

  • 概述
  • 生理食鹽水
  • 生理食鹽水(0.9% NaCl)
  • 高滲透壓鹽溶液
  • 聚葡萄糖
  • 林格氏乳酸鹽溶液
  • 胺基酸
  • 維生素和礦物質
  • 肝素和微量元素
  • 混合溶液

第5章 全球靜脈輸液市場:依輸液袋類型分類,2021-2033年

  • 概述
  • 大容量包裝袋(超過250毫升)
  • 小容量包裝袋(小於250毫升)

第6章 全球靜脈輸液治療解決方案市場:依應用領域分類,2021-2033年

  • 概述
  • 基礎滴液
  • 營養靜脈輸液
  • 血液滴注液
  • 靜脈注射藥物溶液
  • 灌溉滴灌液

第7章 全球靜脈輸液治療解決方案市場:依最終用戶分類,2021-2033年

  • 概述
  • 醫院
  • 診所
  • 門診手術中心
  • 居家醫療

第8章 全球靜脈輸液治療方案市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Baxter International Inc.
    • ICU Medical, Inc.
    • B. Braun Melsungen Ag
    • Grifols, SA
    • Fresenius Kabi USA, LLC
    • Vifor Pharma Management Ltd.
    • JW Life Science
    • Amanta Healthcare
    • Axa Parenterals Ltd
    • Salius Pharma Private Limited.
    • Pfizer, Inc.
    • Otsuka Pharmaceutical Co., Ltd
    • Ajinomoto Co., Inc.
    • Braun Melsungen AG
    • Soxa Formulations & Research Pvt. Ltd
    • Sichuan Kelun Pharmaceutical Co Ltd

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第11章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1134

Intravenous Solutions Market is estimated to be valued at USD 11.77 Bn in 2026 and is expected to reach USD 18.29 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 11.77 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.50% 2033 Value Projection: USD 18.29 Bn

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. Dehydration can contribute to various affects such as

  • Balance of important minerals (electrolytes) in the body.
  • Cognitive (mental) performance.
  • Energy level.
  • Gastrointestinal function (your ability to digest food and create pee and poop).
  • Headache frequency and intensity.
  • Physical performance.
  • Skin health.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, in July 2022, UNICEF (United Nations International Children's Emergency Fund), an agency of the United Nations responsible for providing humanitarian and developmental aid to children worldwide, published a report which accounted for 9 per cent of all deaths among children under age 5 worldwide in 2020 due to Diarrhoea, whereas over 1,300 young children dying each day, or about 484,000 children a year globally due to diarrhoea.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016 globally.

Key features of the study:

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global intravenous solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global intravenous solutions market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global intravenous solutions market.

Detailed Segmentation:

  • Global Intravenous Solutions Market, By Solution type (Revenue, USD Bn, 2021 - 2033)
  • Saline
    • Normal Saline (0.9% NaCl)
    • Hypertonic Saline
  • Dextran
  • Lactated Ringer's
  • Amino Acid
  • Vitamins & Minerals
  • Heparin and Trace Elements
  • Mixed Solutions
  • Global Intravenous Solutions Market, By Bag type (Revenue, USD Bn, 2021 - 2033)
  • Large Volume Bags (greater than 250ml)
  • Small Volume Bags (less than 250ml)
  • Global Intravenous Solutions Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Basic IV Solution
  • Nutritional IV Solution
  • Blood IV Solution
  • Drug IV Solution
  • Irrigation IV Solution
  • Global Intravenous Solutions Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Home Care Settings
  • Global Intravenous Solutions Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • Baxter International Inc.*
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • ICU Medical, Inc.
  • Braun Melsungen Ag
  • Grifols, S.A.
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Healthcare
  • Axa Parenterals Ltd.
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Ajinomoto Co., Inc.
  • Braun Melsungen AG
  • Soxa Formulations & Research Pvt.Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Solution
    • Market Snapshot, By Bag Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Porter's Five Forces Analysis

4. Global Intravenous Solutions Market, By Solution, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Saline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Normal Saline (0.9% NaCl)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Hypertonic Saline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Dextran
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Lactated Ringer's
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Amino Acid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Vitamins & Minerals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Heparin and trace elements
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Mixed Solutions
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Intravenous Solutions Market, By Bag Type, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Large Volume Bags (greater than 250ml)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Small Volume Bags (less than 250ml)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Intravenous Solutions Market, By Application, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Basic IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Nutritional IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Blood IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Drug IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Irrigation IV Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Intravenous Solutions Market, By End User, 2021 - 2033, (US$ Billion)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Ambulatory Surgery Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
  • Home care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global Intravenous Solutions Market, By Region, 2021 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profile
    • Baxter International Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • ICU Medical, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • B. Braun Melsungen Ag
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Grifols, S.A
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Fresenius Kabi USA, LLC
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Vifor Pharma Management Ltd.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • JW Life Science
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Amanta Healthcare
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Axa Parenterals Ltd
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Salius Pharma Private Limited.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Otsuka Pharmaceutical Co., Ltd
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Ajinomoto Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Braun Melsungen AG
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Soxa Formulations & Research Pvt. Ltd
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Sichuan Kelun Pharmaceutical Co Ltd
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact